Per-name detailThe 10 companies, in depth
1. ADBE Adobe Inc.
DEBATED
Software - Application · adj close 219.72 (div-adj)
Quality
97.4% pctile
Market doubt
1.00 / 1.00
News read — a real but unresolved debate — no clear damage yet: HSBC upgrade addresses AI concerns as unresolved secular question; no hard negatives or realized damage.. Leaves the opportunity score about unchanged.
Business quality fingerprint
Returns
ROIC36.7% ▲
ROE61.3%
Gross profitability71.4% ▲
Margins
Gross margin88.6% –
Operating margin36.6% –
FCF margin41.4% (FCF+)
Growth (3-yr)
Revenue CAGR10.5%
EPS CAGR18.2%
Balance sheet
Net debt / EBITDA0.12
Share count (5-yr)-11.2%
Quality score0.88 · 97.4% pctile
What it does
Adobe Inc. stands as a prominent global software provider, delivering a diverse range of solutions. Its operations are structured into three primary business divisions: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment empowers individuals, teams, and enterprises to generate, disseminate, and amplify various forms of content through its array of products and services, including the cloud-native Document Cloud platform.
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 43% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.
Recommended next step
HOLD OFF — CONFIRM THE TURN
The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
2. ZTS Zoetis Inc.
DOUBT = SENTIMENT
Drug Manufacturers - General · adj close 74.80 (div-adj)
Quality
92.8% pctile
Market doubt
1.00 / 1.00
News read — the doubt looks like sentiment, not damage: Price action and valuation commentary only; no hard negatives, earnings misses, regulatory issues, or structural questions.. Lifts the opportunity score to 0.97 (from 0.93).
Business quality fingerprint
Returns
ROIC21.5% ▲
ROE80.2%
Gross profitability43.1% ▲
Margins
Gross margin70.5% ▲
Operating margin38.0% ▲
FCF margin24.1% (FCF+)
Growth (3-yr)
Revenue CAGR5.4%
EPS CAGR10.3%
Balance sheet
Net debt / EBITDA1.76
Share count (5-yr)-6.9%
Quality score0.81 · 92.8% pctile
What it does
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents.
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 52% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -52.3% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
3. TTD The Trade Desk, Inc.
DEBATED
Advertising Agencies · adj close 19.10 (div-adj)
Quality
91.4% pctile
Market doubt
1.00 / 1.00
News read — a real but unresolved debate — no clear damage yet: Analyst downgrade (Arete to Sell) without earnings miss; offsetting upgrade (Guggenheim). Unresolved secular question.. Leaves the opportunity score about unchanged.
Business quality fingerprint
Returns
ROIC13.4% ▲
ROE17.8%
Gross profitability37.0% ▲
Margins
Gross margin78.6% ▼
Operating margin20.3% ▲
FCF margin27.5% (FCF+)
Growth (3-yr)
Revenue CAGR22.4%
EPS CAGR102.2%
Balance sheet
Net debt / EBITDA-0.29
Share count (5-yr)-3.2%
Quality score0.80 · 91.4% pctile
What it does
The Trade Desk, Inc. is a global technology company that provides a self-service, cloud-based platform. This platform enables advertising buyers to efficiently create, manage, and optimize data-driven digital ad campaigns across diverse formats and channels, including display, video, audio, native, and social media, reaching audiences on computers, mobile devices, and connected TVs. In addition to the platform, the company offers various data and value-added services.
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 79% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -78.7% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
4. IT Gartner, Inc.
DEBATED
Consulting Services · adj close 136.32 (div-adj)
Quality
84.4% pctile
Market doubt
1.00 / 1.00
News read — a real but unresolved debate — no clear damage yet: AI disruption to finance/developer talent and costs; real secular question, no realized earnings/guidance miss.. Leaves the opportunity score about unchanged.
Business quality fingerprint
Returns
ROIC18.8% ▲
ROE227.9%
Gross profitability54.4% ▲
Margins
Gross margin67.7% ▼
Operating margin15.8% ▼
FCF margin18.1% (FCF+)
Growth (3-yr)
Revenue CAGR5.9%
EPS CAGR-1.0%
Balance sheet
Net debt / EBITDA1.54
Share count (5-yr)-16.3%
Quality score0.73 · 84.4% pctile
What it does
Gartner, Inc. functions as a premier research and advisory enterprise, extending its reach across the United States, Canada, Europe, the Middle East, Africa, and various international markets. Its operations are structured into three main divisions: Research, Conferences, and Consulting. The Research division primarily offers a subscription service, enabling on-demand access to extensive published studies, data, industry benchmarks, and direct consultations with its expert network.
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 66% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -65.9% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
5. CPRT Copart, Inc.
DOUBT = SENTIMENT
Specialty Business Services · adj close 30.01 (div-adj)
Quality
90.8% pctile
Market doubt
0.87 / 1.00
News read — the doubt looks like sentiment, not damage: CEO departure is a management event, not fundamental damage. No earnings miss, guidance cut, or market-share loss cited.. Lifts the opportunity score to 0.83 (from 0.79).
Business quality fingerprint
Returns
ROIC14.7% ▼
ROE16.9%
Gross profitability20.8% ▼
Margins
Gross margin45.2% ▼
Operating margin36.5% ▼
FCF margin26.5% (FCF+)
Growth (3-yr)
Revenue CAGR9.9%
EPS CAGR12.1%
Balance sheet
Net debt / EBITDA-1.27
Share count (5-yr)+1.7%
Quality score0.79 · 90.8% pctile
What it does
Copart, Inc. stands as a prominent global provider of online vehicle auctions and comprehensive vehicle remarketing services. The company extends its operations across numerous international markets, including the United States, the United Kingdom, Germany, Brazil, Canada, the United Arab Emirates, Spain, Finland, Oman, the Republic of Ireland, and Bahrain. At its core, Copart enables the buying and selling of vehicles over the internet through its sophisticated "virtual bidding" online auction platform.
Doubt & mispricing
The market doubts it (score 0.87): trading cheap versus its own multi-year range; down 40% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -39.9% (skim recent headlines + the last earnings call).
Notable: the balance sheet holds net cash, which de-risks the wait.
Recent news
6. IDXX IDEXX Laboratories, Inc.
DOUBT = SENTIMENT
Medical - Diagnostics & Research · adj close 557.80 (div-adj)
Quality
98.2% pctile
Market doubt
0.77 / 1.00
News read — the doubt looks like sentiment, not damage: No hard negatives. Stock up 3.8%, scheduled earnings/investor day ahead. Pure price action noise.. Lifts the opportunity score to 0.80 (from 0.76).
Business quality fingerprint
Returns
ROIC40.3% ▼
ROE66.0%
Gross profitability79.4% ▲
Margins
Gross margin61.8% ▲
Operating margin31.6% ▲
FCF margin24.5% (FCF+)
Growth (3-yr)
Revenue CAGR8.5%
EPS CAGR17.7%
Balance sheet
Net debt / EBITDA0.61
Share count (5-yr)-6.8%
Quality score0.89 · 98.2% pctile
What it does
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments.
Doubt & mispricing
The market doubts it (score 0.77): trading cheap versus its own multi-year range; down 27% from its 1-year high, below its 200-day line. Early signs of a turn in margins or returns.
Recommended next step
HOLD OFF — CONFIRM THE TURN
The ROIC/margin upturn is only a period or two old. Wait for the next earnings report to confirm it's a trend (not one print), and watch for upward analyst estimate revisions before acting.
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
7. ADSK Autodesk, Inc.
DOUBT = SENTIMENT
Software - Application · adj close 207.48 (div-adj)
Quality
87.4% pctile
Market doubt
0.86 / 1.00
News read — the doubt looks like sentiment, not damage: Price pullback with no hard negatives; valuation debate and options activity are noise, not fundamental damage.. Lifts the opportunity score to 0.79 (from 0.75).
Business quality fingerprint
Returns
ROIC18.7% ▲
ROE36.9%
Gross profitability52.6% ▲
Margins
Gross margin91.0% ▲
Operating margin24.9% ▲
FCF margin33.4% (FCF+)
Growth (3-yr)
Revenue CAGR12.9%
EPS CAGR11.4%
Balance sheet
Net debt / EBITDA0.27
Share count (5-yr)-3.2%
Quality score0.76 · 87.4% pctile
What it does
Autodesk, Inc. delivers advanced software and services for 3D design, engineering, and entertainment to a global clientele. Their diverse product line includes AutoCAD Civil 3D, a comprehensive solution for civil engineering tasks such as land development, transportation infrastructure, and environmental projects. For construction project management, they offer BIM 360, a cloud-based platform.
Doubt & mispricing
The market doubts it (score 0.86): trading cheap versus its own multi-year range; down 37% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -36.5% (skim recent headlines + the last earnings call).
Notable: management is buying back stock into the weakness (shrinking share count) — a tentative confidence signal.
Recent news
8. INTU Intuit Inc.
DEBATED
Software - Application · adj close 275.35 (div-adj)
Quality
78.8% pctile
Market doubt
1.00 / 1.00
News read — a real but unresolved debate — no clear damage yet: Market worried about AI disruption to Intuit's core products; strong Q3 results and raised guidance offset by secular concern.. Leaves the opportunity score about unchanged.
Business quality fingerprint
Returns
ROIC14.8% ▼
ROE19.6%
Gross profitability41.1% ▼
Margins
Gross margin80.8% ▼
Operating margin26.1% –
FCF margin32.3% (FCF+)
Growth (3-yr)
Revenue CAGR14.0%
EPS CAGR23.4%
Balance sheet
Net debt / EBITDA0.64
Share count (5-yr)+3.7%
Quality score0.69 · 78.8% pctile
What it does
Intuit Inc. delivers a comprehensive array of financial management and regulatory compliance solutions, serving individual consumers, small businesses, independent contractors, and accounting professionals across the United States, Canada, and various international markets. The company's operations are structured into four primary divisions: Small Business & Self-Employed, Consumer, Credit Karma, and ProConnect. The Small Business & Self-Employed segment offers the popular QuickBooks ecosystem, which includes cloud-based solutions like QuickBooks Online Advanced, Self-Employed, Commerce (for…
Doubt & mispricing
The market doubts it (score 1.00): trading cheap versus its own multi-year range; down 66% from its 1-year high, below its 200-day line.
Recommended next step
RESEARCH THE CAUSE FIRST
It's both cheap vs its own 5-yr range AND down hard — find out WHY. Read the latest 10-K/10-Q on SEC EDGAR (sec.gov/edgar) and the most recent earnings-call transcript; separate a temporary stumble from a structural problem before treating the discount as opportunity.
Recent news
9. ROL Rollins, Inc.
DOUBT = SENTIMENT
Personal Products & Services · adj close 43.38 (div-adj)
Quality
88.0% pctile
Market doubt
0.85 / 1.00
News read — the doubt looks like sentiment, not damage: CFO turnover and macro uncertainty cited, but no earnings miss, guidance cut, or fundamental damage realized.. Lifts the opportunity score to 0.78 (from 0.75).
Business quality fingerprint
Returns
ROIC20.9% ▲
ROE38.3%
Gross profitability59.2% ▼
Margins
Gross margin49.4% ▼
Operating margin19.4% ▲
FCF margin17.3% (FCF+)
Growth (3-yr)
Revenue CAGR11.7%
EPS CAGR13.3%
Balance sheet
Net debt / EBITDA1.10
Share count (5-yr)-1.6%
Quality score0.77 · 88.0% pctile
What it does
Rollins, Inc. operates a network of subsidiaries that specialize in delivering pest and wildlife management solutions to a diverse clientele, encompassing both homeowners and commercial enterprises, throughout the United States and globally. For residential properties, the company offers comprehensive pest control, safeguarding homes from prevalent invaders such as rodents, insects, and other nuisance animals. Furthermore, it devises tailored pest management strategies for various business sectors, including healthcare, foodservice, and logistics.
Doubt & mispricing
The market doubts it (score 0.85): trading cheap versus its own multi-year range; down 33% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -33.4% (skim recent headlines + the last earnings call).
Recent news
10. RMD ResMed Inc.
DOUBT = SENTIMENT
Medical - Devices · adj close 209.63 (div-adj)
Quality
97.2% pctile
Market doubt
0.73 / 1.00
News read — the doubt looks like sentiment, not damage: Goldman Sachs upgrade drives intraday rally; valuation pullback with no fundamental deterioration or hard negatives.. Lifts the opportunity score to 0.75 (from 0.71).
Business quality fingerprint
Returns
ROIC19.6% ▲
ROE23.5%
Gross profitability37.4% ▼
Margins
Gross margin59.4% ▲
Operating margin32.7% ▲
FCF margin32.3% (FCF+)
Growth (3-yr)
Revenue CAGR12.9%
EPS CAGR21.5%
Balance sheet
Net debt / EBITDA-0.19
Share count (5-yr)+0.6%
Quality score0.88 · 97.2% pctile
What it does
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices.
Doubt & mispricing
The market doubts it (score 0.73): trading cheap versus its own multi-year range; down 28% from its 1-year high, below its 200-day line.
Recommended next step
BUY CANDIDATE — WORTH A CLOSE LOOK
Quality looks intact and cash-generative while the market is clearly doubting it — the doubt reads as price/sentiment more than broken fundamentals. Reasonable to start a small position and add on confirmation; first verify there's no company-specific bad news behind -28.1% (skim recent headlines + the last earnings call).
Notable: the balance sheet holds net cash, which de-risks the wait.
Recent news
